Stuart Randle joined Ivenix in December, 2015 as Chief Executive Officer. Stuart is responsible for designing and executing Ivenix’s growth strategy. Prior to joining Ivenix Stuart served as president and chief executive officer of GI Dynamics, a medical device company developing treatments for type 2 diabetes and obesity. Stuart has over 20 years of experience in the life sciences industry, serving as Entrepreneur in Residence at Advanced Technology Ventures, president and CEO at ACT Medical, Inc., and as a corporate officer at Allegiance Healthcare Corporation, where he was integral to the successful spin-off of Allegiance from Baxter International. Stuart started his career at Baxter Healthcare where he spent 10 years in various senior management positions, including sales and marketing roles in the IV infusion business.
Stuart earned a MBA from The Kellogg Graduate School of Management at Northwestern University and a BS in Mechanical Engineering from Cornell University.